Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)

OBJECTIVE: AIO-PK0104 investigated two treatment strategies in advanced pancreatic cancer (PC): a reference sequence of gemcitabine/erlotinib followed by 2nd-line capecitabine was compared with a reverse experimental sequence of capecitabine/erlotinib followed by gemcitabine. METHODS: 281 patients w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Gut
Glavni autori: Heinemann, Volker, Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C, von Weikersthal, Ludwig Fischer, Clemens, Michael R, Geissler, Michael, Greten, Tim F, Hegewisch-Becker, Susanna, Rubanov, Oleg, Baake, Gerold, Höhler, Thomas, Ko, Yon D, Jung, Andreas, Neugebauer, Sascha, Boeck, Stefan
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309814/
https://ncbi.nlm.nih.gov/pubmed/22773551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2012-302759
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items